Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ross, H.
space
  arrow  Moser, M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Prazosin, Diuretics, and Glucose Intolerance

right arrow Herbert Ross and Marvin Moser

15 October 1993 | Volume 119 Issue 8 | Pages 859-860


TO THE EDITOR:

Pandit and colleagues [1] are to be commended for a concise, comprehensive overview of drug-induced disorders of glucose metabolism. Certain assertions on the effects of diuretics deserve comment, however, because of their wide use in the treatment of patients with hypertension.

The "failure to dramatically reduce" the risk for coronary artery disease in diuretic-based clinical trials may be more illusory than real. A recent meta-analysis of 17 treatment trials in middle-aged and elderly patients with hypertension [2] shows a 16% reduction in the risk for fatal and total coronary events (95% CI, 5% to 26% and 8% to 23%, respectively; P = 0.06 for fatal events and P = 0.0001 for total events). Earlier assertions of lack of benefit relied on data from individual trials of short duration and trials that were not originally designed to test the benefits of a modest reduction in blood pressure for coronary events.

Pandit and colleagues cite an early report of a 30% incidence of glucose intolerance in patients with hypertension who were treated with thiazides. However, the actual observed incidence of new-onset diabetes after administration of large doses of thiazide in the 3- to 5-year diuretic-based intervention trials was considerably lower [3] (Table 1). More recent thiazide-based studies have also confirmed an incidence of less than 1% to 2% in hyperglycemia or diabetes, as well as the fact that coronary mortality is reduced to the same extent in patients with and without diabetes.


View this table:
[in this window]
[in a new window]
 
Table 1. Effects of High-Dose Diuretic Therapy on Glucose Metabolism*

 

Although hypertension may be characterized by an increase in insulin resistance [4] and may be associated with an increased risk for developing glucose intolerance or diabetes, a recent review suggests that the risk is not increased to any greater extent by diuretics when compared with any other hypertensive agents [5].


References
space
up arrowTop
dotReferences

1. Pandit MK, Barke J, Gustafson AB, Minocha A, Peiris AN. Drug-induced disorders of glucose tolerance. Ann Intern Med. 1993; 118: 529-39.

2. Hebert P, Moser M, Mayer J, Glynn RJ, Hennekins CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993; 153:578-81.

3. Moser M, Ross H. The treatment of hypertension in diabetic patients. Diabetes Care. 1993; 16:542-7.

4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987; 317:350-7.

5. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993; 118:273-8.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ross, H.
space
  arrow  Moser, M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online